                         SEQUENCE LISTING

<110>  DANA-FARBER CANCER INSTITUTE, INC.
       KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
       PRESIDENT AND FELLOWS OF HARVARD COLLEGE
 
<120>  DNA NANOSTRUCTURE-BASED VACCINES

<130>  H0498.70692WO00

<140>  PCT/US2020/036281
<141>  2020-06-05

<150>  US 62/858,783
<151>  2019-06-07

<160>  13    

<170>  PatentIn version 3.5

<210>  1
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  1

Ser Ile Ile Asn Phe Glu Lys Leu 
1               5               


<210>  2
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  SITE
<222>  (1)..(5)
<223>  Lysine may be modified by a functional group

<220>
<221>  SITE
<222>  (2)..(2)
<223>  Xaa may be any non-lysine amino acid or Xaa may be absent

<220>
<221>  REPEAT
<222>  (3)..(4)

<220>
<221>  SITE
<222>  (4)..(4)
<223>  Xaa may be any non-lysine amino acid or Xaa may be absent

<400>  2

Lys Xaa Lys Xaa Lys 
1               5   


<210>  3
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  SITE
<222>  (1)..(1)
<223>  Xaa may be any non-lysine amino acid or Xaa may be absent

<220>
<221>  SITE
<222>  (1)..(3)
<223>  Lys may be modified by a functional group

<220>
<221>  REPEAT
<222>  (2)..(3)

<220>
<221>  SITE
<222>  (3)..(3)
<223>  Xaa may be any non-lysine amino acid or Xaa may be absent

<400>  3

Xaa Lys Xaa 
1           


<210>  4
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  SITE
<222>  (1)..(4)
<223>  Lys may be modified by a functional group

<220>
<221>  SITE
<222>  (2)..(2)
<223>  Xaa may be any non-lysine amino acid or may be absent

<220>
<221>  REPEAT
<222>  (3)..(4)

<220>
<221>  SITE
<222>  (4)..(4)
<223>  Xaa may be any non-lysine amino acid or may be absent

<400>  4

Lys Xaa Lys Xaa 
1               


<210>  5
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  SITE
<222>  (1)..(4)
<223>  Lys may be modified by a functional group

<220>
<221>  SITE
<222>  (1)..(1)
<223>  Xaa may be any non-lysine amino acid or may be absent

<220>
<221>  REPEAT
<222>  (2)..(3)

<220>
<221>  SITE
<222>  (3)..(3)
<223>  Xaa may be any non-lysine amino acid or may be absent

<400>  5

Xaa Lys Xaa Lys 
1               


<210>  6
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  SITE
<222>  (1)..(7)
<223>  Lys may be modified by a functional group

<220>
<221>  SITE
<222>  (2)..(3)
<223>  Xaa may be any non-lysine amino acid or may be absent

<220>
<221>  REPEAT
<222>  (4)..(6)

<220>
<221>  SITE
<222>  (5)..(6)
<223>  Xaa may be any non-lysine amino acid or may be absent

<400>  6

Lys Xaa Xaa Lys Xaa Xaa Lys 
1               5           


<210>  7
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  SITE
<222>  (1)..(5)
<223>  Lys may be modified by a functional group

<220>
<221>  SITE
<222>  (1)..(2)
<223>  Xaa may be any non-lysine amino acid or may be absent

<220>
<221>  REPEAT
<222>  (3)..(5)

<220>
<221>  SITE
<222>  (4)..(5)
<223>  Xaa may be any non-lysine amino acid or may be absent

<400>  7

Xaa Xaa Lys Xaa Xaa 
1               5   


<210>  8
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  SITE
<222>  (1)..(6)
<223>  Lys may be modified by a functional group

<220>
<221>  SITE
<222>  (2)..(3)
<223>  Xaa may be any non-lysine amino acid or may be absent

<220>
<221>  REPEAT
<222>  (4)..(6)

<220>
<221>  SITE
<222>  (5)..(6)
<223>  Xaa may be any non-lysine amino acid or may be absent

<400>  8

Lys Xaa Xaa Lys Xaa Xaa 
1               5       


<210>  9
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  SITE
<222>  (1)..(6)
<223>  Lys may be modified by a functional group

<220>
<221>  SITE
<222>  (1)..(2)
<223>  Xaa may be any non-lysine amino acid or may be absent

<220>
<221>  REPEAT
<222>  (3)..(5)

<220>
<221>  SITE
<222>  (4)..(5)
<223>  Xaa may be any non-lysine amino acid or may be absent

<400>  9

Xaa Xaa Lys Xaa Xaa Lys 
1               5       


<210>  10
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  SITE
<222>  (1)..(9)
<223>  Lys may be modified by a functional group

<220>
<221>  SITE
<222>  (2)..(4)
<223>  Xaa may be any non-lysine amino acid or may be absent

<220>
<221>  REPEAT
<222>  (5)..(8)
<223>  Xaa may be any non-lysine amino acid or may be absent

<220>
<221>  SITE
<222>  (6)..(8)
<223>  Xaa may be any non-lysine amino acid or may be absent

<400>  10

Lys Xaa Xaa Xaa Lys Xaa Xaa Xaa Lys 
1               5                   


<210>  11
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  SITE
<222>  (1)..(7)
<223>  Lys may be modified by a functional group

<220>
<221>  SITE
<222>  (1)..(3)
<223>  Xaa may be any non-lysine amino acid or may be absent

<220>
<221>  REPEAT
<222>  (4)..(7)

<220>
<221>  SITE
<222>  (5)..(7)
<223>  Xaa may be any non-lysine amino acid or may be absent

<400>  11

Xaa Xaa Xaa Lys Xaa Xaa Xaa 
1               5           


<210>  12
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  SITE
<222>  (1)..(8)
<223>  Lys may be modified by a functional group

<220>
<221>  SITE
<222>  (2)..(4)
<223>  Xaa may be any non-lysine amino acid or may be absent

<220>
<221>  REPEAT
<222>  (5)..(8)

<220>
<221>  SITE
<222>  (6)..(8)
<223>  Xaa may be any non-lysine amino acid or may be absent

<400>  12

Lys Xaa Xaa Xaa Lys Xaa Xaa Xaa 
1               5               


<210>  13
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  SITE
<222>  (1)..(8)
<223>  Lys may be modified by a functional group

<220>
<221>  SITE
<222>  (1)..(3)
<223>  Xaa may be any non-lysine amino acid or may be absent

<220>
<221>  REPEAT
<222>  (4)..(7)

<220>
<221>  SITE
<222>  (5)..(7)
<223>  Xaa may be any non-lysine amino acid or may be absent

<400>  13

Xaa Xaa Xaa Lys Xaa Xaa Xaa Lys 
1               5               


